It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
7h
MedPage Today on MSNGLP-1 Drugs and Colonoscopy; GI Symptoms Post-COVID; Identifying High-Risk Barrett'sA systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...
A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!
The use of glucagon-like peptide-1 receptor agonists is likely to increase the risks of inadequate bowel preparation for colonoscopy, according to a study published Feb. 12 in The American Journal of ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Morgan Wallen Last week Weeks at no. 1 Weeks on chart Big Loud/Mercury/Republic Gains In Performance Week of February 15, 2025 click to see more Big Loud/Mercury/Republic ...
Laufey Last week Weeks at no. 1 Weeks on chart Laufey/AWAL Greatest gainer this week Gains In Performance Week of February 15, 2025 click to see more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results